North America Anesthesia Drugs Market - Segmented by Drug Type, Route of Administration, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4591602
  • Report
  • Region: North America, United States
  • 80 pages
  • Mordor Intelligence
until Dec 31st 2018
1 of 5


  • Abbott Laboratories
  • AbbVie
  • Astra Zeneca
  • B. Braun Melsungen AG
  • Baxter Healthcare
  • Boehringer Ingelheim
  • MORE
The North America anesthesia drugs market is expected to register a CAGR of 2.1% during the forecast period (2018 - 2023). Anesthetic is a drug which causes anesthesia, it is a reversible loss of sensation. There are several types of anesthetic drugs available in the market, such as the general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia, etc.

Rise in the Number of Surgeries

According to the Center for Disease Control and Prevention (CDC), the total number of inpatient surgeries performed in the United States grew to 51.4 million in 2010 from 48 million in 2009, with the cardiology, surgical, and obstetrical procedures being the most common procedures. The number of surgeries being performed is rising every year. The overall increase in the number of surgeries performed has a strong impact on the anesthetics market, as they are used in all surgical procedures to reduce the pain during surgery. The rise in the number of surgeries as well as other factors, such as new anesthetic drugs, are driving the market.

Side Effects of General Anesthesia

General anesthetic drugs cause several side-effects including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. More serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes, such as blood pressure variations which require a trained anesthesiologist to monitor the patient’s blood pressure levels continuously and to provide blood pressure medications. Carelessness or lack of knowledge of the anesthesiologist could pose potential risks. Hence, the side-effects of general anesthesia and patient’s reluctance towards using it are restraining the segment growth. Other factors like the lack of skilled anesthetics and regulatory issues are also restraining the market growth.

General Anesthesia Drugs Segment to dominate the Market

General anesthesia drugs segment has the largest market share in the anesthesia drugs market. Some of the major driving forces that account for such growth in this segment are the increase in a number of general and emergency surgeries which requires the use of this general anesthesia drugs.

From the technology point of view, advancements in the development of new general anesthesia drugs are a prime driving force for this growth of the general anesthesia segment.

Key Developments in the Market
  • September 2017: AstraZeneca made an agreement with Aspen Global Incorporated (AGI).
  • April 2017: B. Braun and Philips joined forces to innovate in ultrasound-guided regional anesthesia and vascular access.

Reasons to Purchase this Report
  • Current and future anesthesia drugs market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Analyzing the segment that is expected to dominate the market
  • Countries that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative who will ensure you get a report that suits your needs.
Note: Product cover images may vary from those shown
2 of 5


  • Abbott Laboratories
  • AbbVie
  • Astra Zeneca
  • B. Braun Melsungen AG
  • Baxter Healthcare
  • Boehringer Ingelheim
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Number of Surgeries
6.1.2 New Approvals of Anesthetic Drugs
6.2 Market Restraints
6.2.1 Side-Effects of General Anesthetics
6.2.2 Lack of Skilled-Anesthetics
6.2.3 Regulatory Issues
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 Segmentation -by Type
7.1.1 General Anesthesia Drugs Propofol Sevoflurane Desflurane Dexmedetomidine Remifentanil Midazolam Others
7.1.2 Local Anesthesia Drugs Injectable Anesthetics Surface Anesthetics
7.2 Segmentation by Route of Administration
7.2.1 Inhalation
7.2.2 Injection
7.2.3 Others
7.3 Segmentation by Application
7.3.1 General surgeries
7.3.2 Plastic Surgery
7.3.3 Cosmetic surgeries
7.3.4 Dental surgeries
7.3.5 Others
7.4 Segmentation - by Geography
7.4.1 North America United States Canada Mexico

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Baxter Healthcare
9.2 Hospira
9.3 Abbott Laboratories
9.4 Astra Zeneca
9.5 Roche Holding AG
9.6 B. Braun Melsungen AG
9.7 AbbVie
9.8 Boehringer Ingelheim
9.9 Eisai
9.10 Fresenius SE & Co. KGaA
9.11 Others

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Baxter Healthcare
  • Hospira
  • Abbott Laboratories
  • Astra Zeneca
  • Roche Holding AG
  • B. Braun Melsungen AG
  • AbbVie
  • Boehringer Ingelheim
  • Eisai
  • Fresenius SE & Co. KGaA
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown